专题笔谈

氧化应激与铁死亡在糖尿病型阳痿中的相关性研究进展

  • 卢刚刚 ,
  • 李生龙 ,
  • 赵永强 ,
  • 贾云鹏 ,
  • 梁永林 ,
  • 赵渊博
展开
  • 1.甘肃中医药大学,中西医结合学院,(兰州 730000 )
    2.甘肃中医药大学,基础医学院,(兰州 730000 )
    2.甘肃省中医院泌尿外科 (兰州 730050 )
赵永强,男,泌尿外科副主任医师,现任甘肃省中医院副院长。毕业于兰州医学院临床医学专业,从事泌尿外科临床工作20余年。1999年在中国人民解放军总医院泌尿外科进修学习,并参加中美泌尿外科高级培训班,在中西医结合治疗泌尿外科疾病方面积累了丰富的临床经验,对泌尿外科疾病的科研临床最新进展有深入的掌握与研究。目前在研项目共 4 项,发表论文共18篇,其中SCI 2篇,出版专著3部。其中一项科研已申请专利,由兰州军区研究所生产并广泛应用于临床。现承担国家中医药管理局关于中医临床指南应用评价项目临床科研课题,并主持创立泌尿外科具有专科特色的院内制剂(排石汤、八正合剂等)用于泌尿系结石及泌尿系统感染,疗效显著。

收稿日期: 2024-02-21

  网络出版日期: 2024-08-26

基金资助

国家社会科学基金项目(18XMZ031);甘肃省自然科学基金项目(22JR5RA638);甘肃省科学技术厅重点研发项目(22YF7FA101)

Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence

  • Ganggang LU ,
  • Shenglong LI ,
  • Yongqiang ZHAO ,
  • Yunpeng JIA ,
  • Yonglin LIANG ,
  • Yuanbo. ZHAO
Expand
  • *.College of Integrated Traditional Chinese and Western Medicine,Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China

Received date: 2024-02-21

  Online published: 2024-08-26

摘要

糖尿病型阳痿(DMED)是临床上常见糖尿病相关的血管、内分泌及神经病变,DMED患者常表现为勃起困难、勃起所需时间延长、硬度差、性交时间短等症状。其病因机制复杂,常与氧化应激(OS)、炎症反应、神经及内分泌病变等众多因素密切相关,上述因素往往交叉反应,促进DMED病变进展。近年来相关研究表明,OS与铁死亡在DMED中起着关键型作用:OS可致糖尿病患者神经、内分泌功能异常,阴茎血管内皮的合成或生物利用度下降,海绵状内皮细胞功能障碍和平滑肌舒张功能减低,从而导致阴茎勃起障碍;而铁死亡经证实也与DMED密切相关,控制OS和铁死亡以改善糖尿病患者的勃起功能是合理有效的治疗路径,但铁死亡导致DMED的作用机制尚有待进一步研究。因此,文章综述了OS与铁死亡和DMED相关性的最新信息,为探索DMED发生机制、临床防治DMED提供有益参考,并为该领域未来的研究提供潜在方向。

本文引用格式

卢刚刚 , 李生龙 , 赵永强 , 贾云鹏 , 梁永林 , 赵渊博 . 氧化应激与铁死亡在糖尿病型阳痿中的相关性研究进展[J]. 实用医学杂志, 2024 , 40(16) : 2229 -2235 . DOI: 10.3969/j.issn.1006-5725.2024.16.006

Abstract

Diabetes mellitus erectile dysfunction (DMED) is a common diabetic-related vascular, endocrine and neuropathy in clinical practice, and patients with DMED often present with symptoms such as difficulty in erection, prolonged erection time, poor hardness, and short sexual intercourse. The etiological mechanism is complex, and it is often closely related to many factors such as oxidative stress (OS), inflammatory response, and neurological and endocrine lesions, which often cross-react and promote the progression of DMED lesions. In recent years, relevant studies have shown that OS and ferroptosis play a key role in DMED: OS can cause neurological and Abnormal endocrine function, decreased synthesis or bioavailability of penile vascular endothelium, spongy endothelial cell dysfunction and decreased smooth muscle diastolic function, resulting in penile erectile dysfunction, and ferroptosis has also been confirmed to be closely related to DMED, controlling OS and ferroptosis to improve erectile function in diabetic patients is a reasonable and effective treatment pathway, but the mechanism of action of ferroptosis leading to DMED needs to be further studied. Therefore, this article reviews the latest information on the correlation between OS and ferroptosis and DMED, aiming to provide a useful reference for exploring the mechanism of DMED, clinical prevention and treatment of DMED, and providing potential directions for future research in this field.

参考文献

1 LI B, HU P, LIU K, et al. MiRNA‐100 ameliorates diabetes mellitus‐induced erectile dysfunction by modulating autophagy, anti‐inflammatory, and antifibrotic effects[J]. Andrology, 2024.doi: 10.1111/andr.13586 .
2 SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119. doi:10.1016/j.diabres.2023.110945
3 LIU D F, JIANG H, HONG K, et al. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors[J]. Chin Med J (Engl), 2010, 123(22): 3258-3261.
4 LI K, ZHU A, GUTMAN J, et al. Cysteine-Rich Whey Protein Isolate (CR-WPI) Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway[J]. Oxid Med Cell Longev, 2022, 2022: 8151917. doi:10.1155/2022/8151917
5 LI S, ZHENG L, ZHANG J, et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy[J]. Free Radic Biol Med, 2021, 162: 435-449. doi:10.1016/j.freeradbiomed.2020.10.323
6 LI W, LI W, LENG Y, et al. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress[J]. DNA Cell Biol, 2020, 39(2): 210-225. doi:10.1089/dna.2019.5097
7 ZHU Z, DUAN P, SONG H, et al. Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis[J]. Bioengineered, 2021, 12(2): 12555-12567. doi:10.1080/21655979.2021.2010369
8 HAO L, MI J, SONG L, et al. SLC40A1 Mediates Ferroptosis and Cognitive Dysfunction in Type 1 Diabetes[J]. Neuroscience, 2021, 463: 216-226. doi:10.1016/j.neuroscience.2021.03.009
9 WANG X, MA H, SUN J, et al. Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic Osteoporosis[J]. Biol Trace Elem Res, 2022, 200(1): 298-307. doi:10.1007/s12011-021-02627-z
10 SHAMLOUL R, GHANEM H. Erectile dysfunction[J]. Lancet, 2013, 381(9861): 153-165. doi:10.1016/s0140-6736(12)60520-0
11 LI H, CHEN L P, WANG T, et al. Calpain inhibition improves erectile function in diabetic mice via upregulating endothelial nitric oxide synthase expression and reducing apoptosis[J]. Asian J Androl, 2018, 20(4): 342-348. doi:10.4103/aja.aja_63_17
12 ROYCHOUDHURY S, CHAKRABORTY S, CHOUDHURY A P, et al. Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction[J]. Antioxidants (Basel), 2021, 10(6): 837. doi:10.3390/antiox10060837
13 ZIRKIN B R, CHEN H. Regulation of Leydig cell steroidogenic function during aging[J]. Biol Reprod, 2000, 63(4): 977-981. doi:10.1095/biolreprod63.4.977
14 JEREMY J Y, JONES R A, KOUPPARIS A J, et al. Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase[J]. Int J Impot Res, 2007, 19(3): 265-280. doi:10.1038/sj.ijir.3901523
15 ZHANG L, HE Y, JIANG Y, et al. PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation[J]. Cell Death Dis, 2023, 14(4): 233. doi:10.1038/s41419-023-05752-w
16 GAJECKI D, GAWRYS J, WISNIEWSKI J, et al. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus[J]. Nutrients, 2021, 13(7): 2306. doi:10.3390/nu13072306
17 HU L L, ZHANG K Q, TIAN T, et al. Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1/ DDAH/PPAR-γ/eNOS pathways in streptozotocin-induced diabetic rats[J]. Biochem Biophys Res Commun, 2018, 507(1/4): 9-14. doi:10.1016/j.bbrc.2018.10.036
18 CHEN D, ZHANG K Q, LI B, et al. Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway[J]. Asian J Androl, 2017, 19(3): 291-297. doi:10.4103/1008-682x.178486
19 SUN T, XU W, WANG J, et al. Saxagliptin alleviates erectile dysfunction through increasing stromal cell‐derived factor‐1 in diabetes mellitus[J]. Andrology, 2023, 11(2): 295-306. doi:10.1111/andr.13296
20 GALHOM R A, KORAYEM H E, IBRAHIM M A, et al. Urine-Derived Stem Cells Versus Their Lysate in Ameliorating Erectile Dysfunction in a Rat Model of Type 2 Diabetes[J]. Front Physiol, 2022, 13: 854949. doi:10.3389/fphys.2022.854949
21 VOLPE C M O, VILLAR-DELFINO P H, DOS ANJOS P M F, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications[J]. Cell Death Dis, 2018, 9(2): 119. doi:10.1038/s41419-017-0135-z
22 DURAN A M, BEESON W L, FIREK A, et al. Dietary Omega-3 Polyunsaturated Fatty-Acid Supplementation Upregulates Protective Cellular Pathways in Patients with Type 2 Diabetes Exhibiting Improvement in Painful Diabetic Neuropathy[J]. Nutrients, 2022, 14(4): 761. doi:10.3390/nu14040761
23 EISA N H, HELMY S A, EL-KASHEF D H, et al. Pramipexole protects against diabetic neuropathy: Effect on oxidative stress, TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators[J]. Int Immunopharmacol, 2024, 128: 111514. doi:10.1016/j.intimp.2024.111514
24 ZHANG L, BAO B, GUO J, et al. Current status and prospects of diabetes mellitus induced erectile dysfunction: A bibliometric and visualization study[J]. Front Endocrinol (Lausanne), 2023, 14: 1168744. doi:10.3389/fendo.2023.1168744
25 PAUL A, KUMAR M, DAS P, et al. Drug repurposing?A search for novel therapy for the treatment of diabetic neuropathy[J]. Biomed Pharmacother, 2022, 156: 113846. doi:10.1016/j.biopha.2022.113846
26 ESCOBAR-MORREALE H F, MARTINEZ-GARCIA M A, MONTES-NIETO R, et al. Effects of glucose ingestion on circulating inflammatory mediators: Influence of sex and weight excess[J]. Clin Nutr, 2017, 36(2): 522-529. doi:10.1016/j.clnu.2016.01.015
27 WANG Y, LI J, HUANG Y, et al. Tripartite motif?containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR‐1 and -2 and VEGFR2 in endothelial cells[J]. FASEB J, 2017, 31(5): 2026-2036. doi:10.1096/fj.201600988rr
28 NEMKOV T, SUN K, REISZ J A, et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage[J]. Haematologica, 2018, 103(2): 361-372. doi:10.3324/haematol.2017.178608
29 ROJAS D R, TEGEDER I, KUNER R, et al. Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species[J]. J Mol Med (Berl), 2018, 96(12): 1395-1405. doi:10.1007/s00109-018-1707-9
30 MORELLO E, SUTTI S, FOGLIA B, et al. Hypoxia‐inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine‐rich glycoprotein[J]. Hepatology, 2018, 67(6): 2196-2214. doi:10.1002/hep.29754
31 CAROTA I A, KENIG-KOZLOVSKY Y, ONAY T, et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury[J]. J Exp Med, 2019, 216(4): 936-949. doi:10.1084/jem.20180009
32 DUCSAY C A, GOYAL R, PEARCE W J, et al. Gestational Hypoxia and Developmental Plasticity[J]. Physiol Rev, 2018, 98(3): 1241-1334. doi:10.1152/physrev.00043.2017
33 JAIN T, NIKOLOPOULOU E A, XU Q, et al. Hypoxia inducible factor as a therapeutic target for atherosclerosis[J]. Pharmacol Ther, 2018, 183: 22-33. doi:10.1016/j.pharmthera.2017.09.003
34 PHE V, ROUPRET M. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies[J]. Diabetes Metab, 2012, 38(1): 1-13. doi:10.1016/j.diabet.2011.09.003
35 刘洋, 孙岳, 杨安宁, 等. 铁死亡参与高脂饮食诱导的ApoE-/-小鼠动脉粥样硬化及ox-LDL诱导的泡沫细胞形成过程[J]. 实用医学杂志, 2021, 37(5): 585-590. doi:10.3969/j.issn.1006-5725.2021.05.006
36 LI W, LI W, WANG Y, et al. Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury[J]. Cell Death Discov, 2021, 7(1): 267. doi:10.1038/s41420-021-00656-0
37 YAN H F, ZOU T, TUO Q Z, et al. Ferroptosis: mechanisms and links with diseases[J]. Signal Transduct Target Ther, 2021, 6(1): 49. doi:10.1038/s41392-020-00428-9
38 ZHANG S, BEI Y, HUANG Y, et al. Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice[J]. Mol Med, 2022, 28(1): 121. doi:10.1186/s10020-022-00549-7
39 HUANG Z, MA Y, SUN Z, et al. Ferroptosis: potential targets and emerging roles in pancreatic diseases[J]. Arch Toxicol, 2024, 98(1): 75-94. doi:10.1007/s00204-023-03625-x
40 STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease[J]. Cell, 2017, 171(2): 273-285. doi:10.1016/j.cell.2017.09.021
41 LUO E F, LI H X, QIN Y H, et al. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction[J]. World J Diabetes, 2021, 12(2): 124-137. doi:10.4239/wjd.v12.i2.124
42 FANG X, ARDEHALI H, MIN J, et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease[J]. Nat Rev Cardiol, 2023, 20(1): 7-23. doi:10.1038/s41569-022-00735-4
43 CHEN P, CHEN Z, ZHAI J, et al. Overexpression of PRDX2 in Adipose-Derived Mesenchymal Stem Cells Enhances the Therapeutic Effect in a Neurogenic Erectile Dysfunction Rat Model by Inhibiting Ferroptosis[J]. Oxid Med Cell Longev, 2023, 2023: 4952857. doi:10.1155/2023/4952857
44 FENG H, LIU Q, DENG Z, et al. Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis[J]. Stem Cell Res Ther, 2022, 13(1): 450. doi:10.1186/s13287-022-03147-w
45 WANG Y, ZHANG X, CHEN Y, et al. Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction[J]. Andrology, 2023, 11(2): 316-331. doi:10.1111/andr.13265
46 XU W, SUN T, WANG J, et al. GPX4 Alleviates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting Ferroptosis[J]. Antioxidants (Basel), 2022, 11(10): 1896. doi:10.3390/antiox11101896
47 DU S, SHI H, XIONG L, et al. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy[J]. Front Endocrinol (Lausanne), 2022, 13: 1011669. doi:10.3389/fendo.2022.1011669
48 王赛, 高静. 富马酸二甲酯对过氧化氢诱导心脏微血管内皮细胞铁死亡的影响[J]. 实用医学杂志, 2023, 39(12): 1494-1499. doi:10.3969/j.issn.1006-5725.2023.12.006
49 FENG X, WANG S, SUN Z, et al. Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice[J]. Front Endocrinol (Lausanne), 2021, 12: 626390. doi:10.3389/fendo.2021.626390
50 WU Y, ZHAO Y, YANG H Z, et al. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose[J]. Biosci Rep, 2021, 41(2): BSR20202924. doi:10.1042/bsr20202924
文章导航

/